View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
February 10, 2020updated 13 Feb 2020 10:16am

UK distributes new coronavirus diagnostic test

The UK has launched a new coronavirus diagnostic test to boost its testing capabilities as the outbreak in China continues.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

Follow the latest updates of the outbreak on our timeline.

The UK has launched a new coronavirus diagnostic test to boost its testing capabilities as the outbreak in China continues.

As of 9 February, 2019-nCoV has killed 910 people, with the number of confirmed cases surging to 40,547 globally. In the UK, four people received disease diagnosis.

Developed by Public Health England (PHE), the test will equip 12 laboratories over the coming weeks to test coronavirus.

The move will enable testing of more than 1,000 people a day. Currently, only one lab in London can carry out the test, which can examine around 100 samples daily.

Public Health England medical director Yvonne Doyle said: “Once China confirmed that they had identified a novel coronavirus, Public Health England was ready to test potential cases in this country.

“We have now trained scientists in labs across the UK to conduct the specialist test, ensuring that we are well prepared should we begin to see an increased number of cases across the country.”

The test allows researchers to identify any coronavirus strain, with samples taken from the nose, throat and lower respiratory tract.

Following this, researchers at PHE’s Colindale laboratories will subsequently conduct a confirmatory test.

Last week, US-based Co-Diagnostics launched a research use only (RUO) CoPrimer test for 2019-nCoV.

Novacyt’s molecular diagnostics division Primerdesign also introduced a molecular RUO test. Later, Novacyt applied for US Food and Drug Administration approval to allow nCoV test for clinical diagnostic testing in laboratories provisionally.

 

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU